A Silent Attacker SARS-CoV-2 - A Review

##plugins.themes.bootstrap3.article.main##

  •   Khoshnur Jannat

  •   Nusratun Nahar

  •   Md Shahadat Hossan

  •   Tohmina Afroze Bondhon

  •   Anamul Hasan

  •   Anita Paul

  •   Rownak Jahan

  •   Mohammed Rahmatullah

Abstract

The recent coronavirus (known as COVID-19 or SARS-CoV-2) has created a pandemic of unheard proportions affecting virtually every country and region of the world. As of April 15, 2020 the virus has resulted in over 2 million infections, and over 100,000 deaths and has brought world economic activities to a standstill, and has led to social isolation and massive unemployment with possible economic recessions on an unprecedented scale around the corner. Till now, the virus shows no signs of abatement. Also till now, scientists have not been able to come out with an effective drug or vaccine against the virus. This review attempts to give a comprehensive view of the origin of the virus, the mode of its entry and infecting human beings, and further discusses the possibility of new drugs and vaccines against the virus.


Keywords: COVID-19, SARS-CoV-2, coronavirus, anti-viral drugs, ACE2

References

Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet, 2020, 395(10223):470-473. doi: 10.1016/S0140-6736(20)30185-9.

Rahman S, Bahar T. COVID-19: The New Threat. International Journal of Infection, 2020, 7(1):e102184. doi: 10.5812/iji.102184.

Worldometer. https://www.worldometers.info/coronavirus/. Accessed on 15th April, 2020.

Sahin AR, Erdogan A, Agaoglu PM, Dineri Y, Cakirci AY, Senel ME, Okyay RA, Tasdogan AM. 2019 Novel corona virus (COVID-19) outbreak: A review of the current literature. Eurasian Journal of Medicine and Oncology, 2020; 4(1): 1-7. doi: 10.14744/ejmo.2020.12220.

Woo PCY, Huang Y, Lau SKP, Yuen KY. Coronavirus genomics and bioinformatics analysis. Viruses 2010, 2, 1804-1820; doi:10.3390/v2081803.

Kannan S, Ali PSS, Sheeza A, Hemalatha K. COVID-19(Novel coronavirus 2019)- recent trends. European Review for Medical and Pharmacological Sciences, 2020, 24: 2006-2011.

McBride R, Marjorie van Zyl, Fielding BC. The coronavirus nucleocapsid is a multifunctional protein. Viruses, 2014, 6(8): 2991-3018.

Rottier P.J.M. (1995), The Coronavirus Membrane Glycoprotein. In: Siddell S.G. (eds) The Coronaviridae. The Viruses. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1531-3_6.

Li F. Structure, function and evolution of coronavirus spike proteins. The Annual Review of Virology, 2016, 3, 237-261.

Coronavirus: 7 types of human coronavirus https://en.as.com/en/2020/03/27/other_sports/1585319003_056685.html. Accessed on 16th April, 2020.

Hassan S, Sheikh FN, Jamal s, Ezeh JK, Akhter A. Coronavirus (COVID-19): A review of clinical features, diagnosis, and treatment.Cureus 12(3): e7355. Doi:10.7759/cureus.7355.

Wu Y, Ho W, Huang Y, Dong-Yan J, Li S, Shan-Lu L, Liu X, Qiu J, Sang Y, Wang Q, Kwok-Yung Y, Zhi-Ming Z. SARS-CoV-2 is the appropriate name for the coronavirus. The Lancet, 2020, 395(10228): P949-P950. Doi:https://doi.org/10.1016/S0140-6736(20)30557-2.

Foley KE. The coronavirus’s survival mechanism is what makes it so dangerous. QUARTZ. https://qz.com/1822554/how-the-coronavirus-tricks-cells-into-a-full-body-invasion/.

Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, Li T, Chen Q. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. International Journal of Oral Science 12, 8 (2020). Doi: https://doi.org/10.1038/s41368-020-0074-x.

Clarke NE, Turner AJ. Angiotensine-converting enzyme 2: The first decade. International Journal of Hypertension 2012, V-2012; Art.ID-307315. doi:10.1155/2012/307315.

Hamming I, Timens W, Bulthuis M, Lely T, Navis G, Goor HV. Tissue distribution of ACE2 protein, the functional receptor for SARS Coronavirus. Journal of Pathology 2004, 203(2): 631-637.

Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application. Annals of Internal Medicine 2020, doi: 10.7326/M20-0504

He J, Tao H, Yan Y, Sheng-You H, Xiao Y. Molecular mechanisms of evolution and human infection with SARS-CoV-2. Viruses 2020, 12, 428.

Gui M, Song W, Zhou H, Xu J, Chen S, Xiang Y, Wang X. Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding. Cell Res.2017, 27, 119–129.

Li, W.; Moore, M.J.; Vasilieva, N.; Sui, J.; Wong, S.K.; Berne, M.A.; Somasundaran, M.; Sullivan, J.L.; Luzuriaga, K.; Greenough, T.C.; et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003, 426, 450–454.

Song W, Gui M, Wang X, Xiang Y. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Pathog. 2018, 14, e1007236

Gracia-Ramos AE. Is the ACE2 overexpression a risk factor for COVID-19 infection? Archives of Medical Research 2020. doi: 10.1016/j.arcmed.2020.03.011.

Jia PH, Look DC, Shi L, Hickey M, Pewe L, Netland J, Farzan M, Wohlford-Lenane C, Perlman S, McCray Jr. PB. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. Journal of virology 2005, 79(23): 14614-14621.

Adhikari SP, Meng S, Yu-Ju W, Yu-Ping M, Rui-Xue Y, Qing-Zhi W, Sun C, Sylvia S, Rozelle S, Raat H, Zhou H. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infectious diseases of poverty 2020. 9(29). https://doi.org/10.1186/s40249-020-00646-x.

Liu T, Hu J, Kang M, Lin L, Zhong H, Xiao J, He G, Song T, Huang Q, Rong Z, Deng A, Zeng W, Tan X, Zeng X, Zhu Z, Li J, Wan D, Lu J, Deng H, He J, Ma W.. Transmission dynamics of 2019 novel coronavirus (2019-nCoV). bioRxiv 2020; doi: https://doi.org/10.1101/2020.01.25.919787.

] Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. The New England Journal of Medicine. 2020. https://doi.org/10.1056/NEJMoa2001316.

He Y, Zheng C. Replication and transmission mechanisms of highly pathogenic human coronaviruses. Zheijiang Da Xue Xue Bao YiXue Ban 2020, 49(1). https://www.ncbi.nlm.nih.gov/pubmed/32298055.

Morawska L, Cao J. Airborne transmission of SARS-CoV-2: The world should face the reality. Environment International 2020. 139:105730. doi: 10.1016/j.envint.2020.105730.

Meselson M. Droplets and Aerosols in the transmission of SARS-CoV-2. The New England Journal of Medivine 2020. doi: 10.1056/NEJMc2009324.

Shivhare SB, Lash EG. Chapter114- Immunity at the maternal-fetal interface. Mucosal Immunology (Fourth Edition) 2015, 2: 2231-2250.

Li M, Chen L, Zhang J, Xiong C, Li X. The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single cell transcriptome study. PLoS One 2020, 15 (4): e0230295. doi: 10.1371/journal.pone.0230295.

de Niet A, Waanders BL, Walraven I. The role of children in the transmission of mild SARS-CoV-2 infection. Acta Paediatrica 2020. doi: 10.1111/apa.15310.

Singhal T. A review of coronavirus disease-2019 (COVID-19). The Indian Journal of Pediatrics 2020. https://doi.org/10.1007/s12098-020-03263-6.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020, 395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020, 395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7.

Xu X, Yu C, Qu J, Zhang L, Jiang S, Huang D, Chen B, Zhang Z, Guan W, Ling Z, Jiang R, Hu T, Ding Y, Lin L, Gan Q, Luo L, Tang X, Liu J. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. European Journal of Nuclear Medicine and Molecular Imaging 2020, 47(5):1275-1280. doi: 10.1007/s00259-020-04735-9.

Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults. Pediatric Pulmonology 2020, 55(5):1169-1174. doi: 10.1002/ppul.24718.

Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of the clinical characteristics of coronavirus diseases 2019 (COVID-19). Journal of General Internal Medicine 2020, doi: 10.1007/s11606-020-05762-w.

Shoenfeld Y. Corona (COVID-19) time musing: Our involvement in COVID-19 pathogenecies, diagnosis, treatment and vaccine planning. Autoimmunity Reviews 2020, 102538. doi: 10.1016/j.autrev.2020.102538.

Kokkinakis I, Selby K, Favrat B, Genton B, Cornuz J. Covid-19 dagnosis: clinical recommendations and performance of nasopharyngeal swab-PCR. Revue Medicale Suisse 2020, 16(689):699-701.

Unhale SS, Ansar QB, Sanap S, Thakhre S, Wadatkar S, Bairagi R, Sagrule S, Biyani KR. A review on coronavirus (COVID-19). World Journal of Pharmaceutical and Life Sciences 2020, 6(4): 109-115.

World Health Organization. (2020). Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020. https://apps.who.int/iris/handle/10665/331329

Sheridan C. Fast, portable tests come online to curb coronavirus pandemic. Nat Biotechnol. 2020. [PMID: 32203294] doi:10.1038/d41587-020-00010-2.

Prendergast C, Papenburg J. Rapid antigen-based testing for respiratory syncytial virus: moving diagnostics from bench to bedside? Future Microbiol. 2013;8:435-44. [PMID: 23534357] doi:10.2217/fmb.13.9.

Cheng MP, Papenburg J, Desjardins M, Kanjilal S4, Quach C, Libman M, Dittrich S, Yansouni CP. Diagnostic testing for severe acute respiratory syndrome-related coronavirus-2: a narrative review. Annals of Internal Medicine 2020, doi: 10.7326/M20-1301.

Zhang Z, Shen Y, Wang H, Zhao L, Hu D. High-resolution computed tomographic imaging disclosing COVID-19 pneumonia: a powerful tool in diagnosis. The Journal of Infection 2020, pii: S0163-4453(20)30178-X. doi: 10.1016/j.jinf.2020.03.047.

World Health Organization 2020. Clinical management of severe acute respiratory infection when COVID-19 is suspected. 13 March, 2020. Reference Number: WHO/2019-nCoV/clinical/2020.4. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected.

National Health Commission of the People’s Republic of China. Notice on the issunance of guidelines of diagnosis and treatment for 2019-nCoV infected pneumonia (version 6). 6 ed; http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml?from=timeline. 2020.

Yang Y, Islam SM, Wang J, Li Y, Chen X. Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): a Review and Perspective. International Journal of Biological Sciences 2020; 16(10): 1708-1717. doi: 10.7150/ijbs.45538.

Mitza O, Clotet B. Use of antiviral drugs to reduce COVID-19 transmission. The Lancet Global Health 2020, DOI:https://doi.org/10.1016/S2214-109X(20)30114-5.

Ye XT, Luo YL, Xia SC, Sun QF, Ding JG, Zhou Y, Chen W, Wang XF, Zhang WW, Du WJ, Ruan ZW, Hong L. Clinical efficacy of lopinavir/ritonavir in the treatment of coronavirus disease 2019. European Review for Medical and Pharmacological Sciences 2020, 24(6):3390-3396. doi: 10.26355/eurrev_202003_20706.

Stebbing J, Phelan A, Griffin I, Tucker C, Oechsle O, Smith D, Richardson P. COVID-19: combining antiviral and anti-inflammatory treatments. The Lancet Infectious Diseases 2020, 20(4): P400-402.

Bizzarri M, Laganà AS, Aragona D, Unfer V. Inositol and pulmonary function. Could myo-Inositol downregulate inflammation and cytokine release syndrome in SARS-CoV-2? European Review for Medical and Pharmacological Sciences 2020, 24(6):3426-3432. doi: 10.26355/eurrev_202003_20715.

Tchesnokov PE, Feng JY, Porter DP, Götte M. Mechanism of inhibition of ebola virus RNA-dependent RNA polymerase by remdesivir. Viruses 2019, 11(326). doi:10.3390/v11040326.

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research 2020, 30(3): 269-271. doi: 10.1038/s41422-020-0282-0.

Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A et.al. Compassionate use of remdesivir for patients with severe COVID-19. The New England Journal of Medicine 2020, doi: 10.1056/NEJMoa2007016.

Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in the treatment of COVID-19 associated pneumonia in clinical studies. Bioscience Trends 2020, 14(1):72-73. doi: 10.5582/bst.2020.01047.

Moore, N. Chloroquine for COVID-19 Infection. Drug Safety 43, 393–394 (2020). https://doi.org/10.1007/s40264-020-00933-4

Slater AF. Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum. Pharmacology Therapy 1993, 57(2-3): 203-235. Doi: 10.1016/0163-7258(93)90056-j.

Gautret et al. (2020) Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial. International Journal of Antimicrobial Agents – In Press 17 March 2020 – DOI : 10.1016/j.ijantimicag.2020.105949.

Jiun-Ji S, Jim-Min F. Development of effective anti-influenza drugs: congeners and conjugates- a review. The Journal of Biomedical Science 2019, 26:84, doi: 10.1186/s12929-019-0567-0.

Costanzo M, De Giglio MAR, Roviello GN. SARS CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus. Current Medicinal Chemistry 2020, doi: 10.2174/0929867327666200416131117.

Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et.al. A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19. The New England Journal of Medicine 2020, DOI: 10.1056/NEJMoa2001282.

Baden LR and Rubin EJ. Covid-19 — The search for effective therapy. The New England Journal of Medicine 2020 Mar 18; [e-pub]. (https://doi.org/10.1056/NEJMe2005477).

Kutlu Ö, Metin A. (2020). A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic? Dermatologic Therapy, e13383. doi:10.1111/dth.13383.

Kassi EN, Papavassiliou K A, Papavassiliou AG. (2020). G6PD and chloroquine: selecting the treatment against SARS-CoV-2? Journal of Cellular and Molecular Medicine. doi:10.1111/jcmm.15312.

Zhan WQ, Li MD, Xu M, Lu YB. Successful treatment of COVID-19 using extracorporeal membrane oxygenation, a case report. European Review for Medical and Pharmacological Sciences 2020, 24(6):3385-3389. doi: 10.26355/eurrev_202003_20705.

Sallard E, Lescure FX, Yazdanpanah Y, Mentre F, Peiffer-Smadja N. Type 1 interferons as a potential treatment against COVID-19. Antiviral Research 2020, 178:104791. doi: 10.1016/j.antiviral.2020.104791.

Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA. Published online April 13, 2020. doi:10.1001/jama.2020.6019.

Gallagher J. Coronavirus: Are we getting closer to a vaccine or drug. BBC News. https://www.bbc.com/news/health-51665497. Accessed on 20th April, 2020.

Ryan J. Coronavirus treatments: hydroxychloroquine, vaccines and drugs for COVID-19. https://www.cnet.com/how-to/coronavirus-treatments-hydroxychloroquine-vaccines-and-drugs-for-covid-19/. Accessed on 20th April, 2020.

Medscape. Oxford COVID-19 Vaccine Trial ‘Within Weeks’ : Q&A. https://www.medscape.com/viewarticle/928941. Accessed on 21th April, 2020.

Golchin A, Seyedjafari E, Ardeshirylajimi A. Mesenchymal stem cell therapy for COVID-19: present and future. Stem Cell Reviews and Reports 2020, doi: 10.1007/s12015-020-09973-w.

Jo S, Kim S, Shin DH, Kim M.-S. Inhibition of SARS-CoV 3CL protease by flavonoids. Journal of Enzyme Inhibition and Medicinal Chemistry 2020, 35(1):145-151. https://doi.org/10.1080/14756366.2019.1690480.

Shen K, Yang Y, Wang T, Zhao D, Jiang Y, Jin R, Zheng Y et.al. Diagnosis, treatment and prevention of 2019 novel coronavirus infection in children: expert’s consensus statement. World Journal of Pediatrics 2020, DOI: 10.1007/s12519-020-00343-7.

Downloads

Download data is not yet available.

##plugins.themes.bootstrap3.article.details##

How to Cite
Jannat, K., Nahar, N., Hossan, M., Bondhon, T., Hasan, A., Paul, A., Jahan, R., & Rahmatullah, M. (2020). A Silent Attacker SARS-CoV-2 - A Review. European Journal of Medical and Health Sciences, 2(3). https://doi.org/10.24018/ejmed.2020.2.3.246